Cryoport, Inc. (CYRX)
CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Brentwood, TN.
Address
112 WESTWOOD PLACE, SUITE 350
BRENTWOOD, TN 37027
Founded
1990
Number of Employees
1,170
Website
http://www.cryoport.com
Buyback
Buyback Data | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
---|---|---|---|---|---|---|---|---|---|---|---|---|
$ Amount Purchased ($ in 000s ) |
- | - | - | - | - | - | - | $8,344 | $43,794 | - | - | $26,069 |
Average Price | - | - | - | - | - | - | - | $27.24 | $24.65 | - | - | $25.03 |
# Shares Purchased | - | - | - | - | - | - | - | 306,300 | 1,776,842 | - | - | 1,041,571 |
Buyback Performance | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Return to Date | - | - | - | - | - | - | - | -70.6% | -67.5% | - | - | -68.0% |
S&P 500 Return to Date | - | - | - | - | - | - | - | 31.7% | 37.3% | - | - | 34.5% |
Excess Total Return | - | - | - | - | - | - | - | -102.3% | -104.8% | - | - | -102.5% |
Quartile Rank |
|
|
|
|
|
|
|
|
|
|
|
|
Percentile Rank | - | - | - | - | - | - | - | 6% | 6% | - | - | 8% |
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)